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Assessment of atrial size, anatomy and function is
important in various clinical settings and can be
performed with different imaging techniques. Assess-
ment of atrial size provides important prognostic
information and is routinely performed with trans-
thoracic echocardiography. Information on regional
atrial function can also be provided by transthoracic
echocardiography and is important in the setting of
treatment of atrial ﬁbrillation. Catheter ablation
procedures for atrial ﬁbrillation require accurate
imaging of the left atrium and surrounding structures.
Intracardiac echocardiography, multislice computed
tomography (CT), and cardiovascular magnetic res-
onance imaging (CMR) may provide detailed
information on right and left atrium and pulmonary
vein anatomy [1].
The atria perform three different functions during
the various phases of the cardiac cycle, i.e. serving as
reservoir during systole, passive conduit during early
diastole, and booster function during late diastole. In
this issue of the journal, Willens et al. report a
descriptive study on the effects of age and pulmonary
arterial hypertension on all three phases of right atrial
function by measuring changes in right atrial volume
during the cardiac cycle using two-dimensional
transthoracic echocardiography [2]. In their study,
Willens et al demonstrated that passive right atrial
emptying was lower and booster function was greater
in older healthy subjects and in patients with
pulmonary arterial hypertension. Reservoir function
was higher in pulmonary hypertension. These
changes are analogous to the changes reported in
the left atrium in response to increased afterload and
impaired relaxation [3].
The active contractile component of the atria has
an important role in patients with ventricular dys-
function to augment ventricular volume. Augmented
atrial booster function is one of the mechanisms
compensating for decreased early ﬁlling in patients
with reduced ventricular compliance. Loss of atrial
contraction as a result of atrial ﬁbrillation or ventric-
ular pacing reduces cardiac output by approximately
15–20%. The ability to optimally redistribute ven-
tricular ﬁlling among reservoir, conduit and booster
pump functions is a potentially important adaptation
that may occur in the atria in response to changing
dynamics.
In patients with congenital or valvular heart
disease, increased ventricular stiffness or decreased
ventricular compliance may cause an increased atrial
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DOI 10.1007/s10554-008-9323-3pressure. The increased atrial wall tension leads to
stretch and dilation of the atrial myocardium. Thus,
atrial volume increases with severity of diastolic
dysfunction.
Atrial volume is a barometer of ventricular ﬁlling
pressure and reﬂects the burden of diastolic dysfunc-
tion in subjects without atrial ﬁbrillation or
signiﬁcant valve disease. Atrial enlargement carries
important clinical and prognostic implications [1, 3].
In large population- based studies it has been
demonstrated that left atrial size is an important
predictor of cardiovascular outcome. Elevation of
ﬁlling pressure is uniformly found in the presence of
symptomatic congestive heart failure. Evidence for a
prognostic role for left atrial volume to predict
incident congestive heart failure is emerging [3]. In
the general population left atrial size has been
determined to be a predictor of stroke and death.
The relationship between left atrial size and death has
been demonstrated in high-risk groups, such as
patients with dilated cardiomyopathy, left ventricular
dysfunction, atrial arrhythmias, acute myocardial
infarction, patients undergoing valve replacement
for aortic valve stenosis and mitral regurgitation [3].
Left atrial size is potentially modiﬁable with
medical therapy, but whether left atrial size reduction
translates to improved outcomes remains to be
established.
Atrial ﬁbrillation is another important factor
associated with atrial dilatation. Atrial enlargement
may be the consequence of atrial ﬁbrillation, but
atrial enlargement may also lead to atrial ﬁbrillation
[1, 3]. To what extent the shifts among reservoir,
conduit and booster pump functions of the atria
contribute to the development of atrial arrhythmias
warrants further study.
The atria play an important role in adult congenital
heart disease [4]. Atrial function is often altered due
to longstanding pressure or volume overload. More-
over, many adult patients with a congenital heart
defect have had intracardiac surgery with the use of
cardiopulmonary bypass in the past. These patients
will all have a right atrial scar, the sequel of the
atriotomy necessary for the cannulation for the
cardiopulmonary bypass or necessary for visualisa-
tion of intracardiac structures. This scarring leads to
loss of atrial compliance and compromises atrial
reservoir function. Moreover, atrial function can be
substantially modiﬁed by some forms of surgical
correction or palliation, such as the Mustard or
Senning procedure in patients with transposition of
the great arteries or a Fontan operation in patients
with univentricular hearts [5–10]. Cardioplegic arrest
may also cause deterioration of right atrial function.
Altered caval vein ﬂow patterns indicate abnormal
atrial ﬁlling and the reservoir function of the right
atrium is diminished postoperatively. Both the long-
standing atrial overload and the atrial scarring form
substrates for atrial arrhythmias. Loss of atrial
reservoir function (reduced compliance) and the loss
of booster function (atrial ﬁbrillation) is poorly
tolerated in patients with a compromised ventricular
function.
In patients with right ventricular hypertrophy, such
as in pulmonary arterial hypertension or in corrected
tetralogy of Fallot, the forceful right ventricular
contraction leads to an increased downward displace-
ment of the tricuspid valve annulus, thereby
increasing atrial ﬁlling from the pulmonary veins
during systole. The antegrade pulmonary ﬂow during
diastole is decreased due to a decreased compliance.
The higher ﬁlling pressures will cause a more forceful
atrial contraction. Right ventricular volume overload,
due to pulmonary regurgitation and/or tricuspid
regurgitation in Fallot patients will also elevate right
atrial pressure and volume. Either due to elevated
right ventricular pressure or as a result of increased
right ventricular volume, the right atrial wall is often
stretched in patients with corrected tetralogy of
Fallot. This will not only lead to an altered atrial
function, but also to a high prevalence of atrial
arrhythmias. In case of atrial ﬁbrillation, the contri-
bution of the atrial booster will then disappear, which
may substantially worsen the hemodynamic status in
these patients [11–22].
The longterm prognosis of adult patients with
congenital heart disease is insufﬁciently known and
largely dependent on right-sided cardiac function
[23–26]. Noninvasive follow-up modalities are of
utmost importance for these patients, in order to
allow early detection of pressure or volume overload
of the right ventricle before the occurrence of failure
or irreversible myocardial damage. Early detection of
right ventricular dysfunction may allow timely med-
ical management and preventive surgery. CMR
provides the diagnostic imaging of choice for the
evaluation of right sided heart anatomy and function
in congenital heart disease by its potential to obtain
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123both anatomic detail and ﬂow quantiﬁcation [27–29].
CMR is useful for detecting intra- and extra-cardiac
conduit obstruction following cardiac surgery in
complex congenital heart disease. Technical
advances of CMR are the excellent spatial resolution,
the characterisation of myocardial tissue, multiplane
versatility and the potential for three-dimensional
imaging. By means of dobutamine stress cardiac
reserve may be determined in various forms of
congenital heart disease. In addition, the use of
plasma neurohormones may play a role in early
detection of cardiac dysfunction in asymptomatic
patients with congenital heart defects [30–35].
The utility of atrial volume and function for
monitoring cardiovascular risk and for guiding ther-
apy becomes increasingly clear and may prove to
have an important impact in clinical decision making.
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